Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 23: COP-AF: Colchicine for Perioperative AF
Author(s): David Conen Added: 7 months ago
ESC 2023 — Dr David Conen (McMaster University, CA) joins us onsite for a short interview focussing on the findings from the COP-AF trial (NCT03310125). COP-AF (Population Health Research Institute) aimed to assess if oral colchicine reduced the incidence of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery. 3209… View more

Electrophysiology & Arrhythmia
Colchicine, coronary artery disease, myocardial infarction, mortality
Author(s): Francesco Condello , Matteo Sturla , Bernhard Reimers , et al Added: 2 years ago

MI/ACS
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19
Author(s): Sanjit Jolly Added: 1 year ago
ESC Congress 22 — Dr Sanjit Jolly (Population Health Research Institute, CA) talk about the Anti-Coronavirus Therapies (ACT) trials (NCT04324463). The data is from two parallel trials assessing the effects of interventions in inpatients and outpatients with COVID-19. The ACT trials are testing whether anti-inflammatory therapy with colchicine and antithrombotic therapy with aspirin in… View more

Anticoagulation

Vascular Disease and Surgery
European Society of Cardiology Highlights: Late-breaking Trials – COVID-19
Author(s): Maki Komiyama , Koji Hasegawa Added: 2 years ago

Anticoagulation

COVID-19
Anti-inflammatory Treatment and Cardiovascular Outcomes
Author(s): Alberto Lorenzatti Added: 2 years ago

Prevention & Chronic Conditions
Inflammation and Cardiovascular Disease: The Future
Author(s): Natalie Arnold , Katharina Lechner , Christoph Waldeyer , et al Added: 2 years ago

Prevention & Chronic Conditions
Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
Author(s): Akira Matsumori Added: 1 year ago

Imaging & Diagnostics

Heart Failure
AHA 23: Preventive Cardiology in 2023
Author(s): Michael Honigberg Added: 4 months ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation… View more

Standards & Guidelines

Prevention & Chronic Conditions
Author(s): Wolfgang Koenig Added: 3 years ago
The notion that atherosclerosis carries features of an inflammatory disease has existed for quite some time. As early as 1856, Rudolf Virchow in his Textbook on Pathology mentioned the term “coronaritis”. Almost 150 years later, following the elucidation of major cardiovascular risk factors in the 1950s Framingham Study, Russell Ross entitled his 1999 review on mechanisms of atherosclerosis … View more

Heart Failure

Prevention & Chronic Conditions
AHA 2019 - Results of the COLCOT Trial
Author(s): Jean-Claude Tardif Added: 4 years ago
Prof Jean-Claude Tardif (University of Montreal & Montreal Heart Institute, Montreal, QC, CA) discusses the results of the COLCOT Trial. Questions: 1. What is colchicine and what is the COLCOT study? 2. Could you describe the study design, patient population and endpoints? 3. What were your findings? 4. Does this study fully validate the anti-inflammation hypothesis and transcend into practice?… View more

Prevention & Chronic Conditions

MI/ACS